Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Cydectin 5 mg Solution is a Health Canada–registered veterinary drug (DIN 02228386) held by Boehringer Ingelheim (Canada) Ltd Ltee, containing Moxidectin. Health Canada lists its status as Cancelled Post Market (status date 31 Jan 2018). Nexara Health has matched 22 registrations of Moxidectin across 6 other regulated markets.

Health Canada registration

DIN02228386
Brand nameCydectin
Active ingredientMoxidectin
Strength5 mg
Dosage formSolution
RouteTopical
CompanyBoehringer Ingelheim (Canada) Ltd Ltee
StatusCancelled Post Market — 31 Jan 2018
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Moxidectin registered in other markets

22 registrations of the same molecule in 6 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
DenmarkCydectin Vet.Zoetis Animal Health ApS10 mg/mlinjektionsvæske, opløsningMRPLaegemiddelstyrelsen
DenmarkCydectin Vet.Zoetis Animal Health ApS1 mg/mloral opløsningMRPLaegemiddelstyrelsen
DenmarkEquest Vet.Zoetis Animal Health ApSoral gelMRPLaegemiddelstyrelsen
DenmarkRidamecChanelle Pharmaceuticals Manufacturing Limited1 mg/mloral opløsningMRPLaegemiddelstyrelsen
Hong KongProheart SR-12 Inj Once-A-Year (Vet)Pah 7v6 Holding LimitedRegisteredDH Drug Office
IcelandCydectinParlogis - óskráð lyf0,1 %mixtúra0Lyfjastofnun lyfjaverdskra
IcelandCydectinParlogis - óskráð lyf0,1 %mixtúra0Lyfjastofnun lyfjaverdskra
IcelandCydectinParlogis - óskráð lyf0,1 %mixtúra0Lyfjastofnun lyfjaverdskra
IcelandMoxodexParlogis - óskráð lyf0,1 %mixtúra0Lyfjastofnun lyfjaverdskra
IcelandMoxodexParlogis - óskráð lyf0,1 %mixtúra0Lyfjastofnun lyfjaverdskra
MalaysiaProheart SR-12 10mg/mL Injection For DogsZoetis Malaysia Sdn. Bhd.VeterinaryPRODUCT APPROVEDNPRA
PolandEquimoxinBioveta, a.s.18,92 mg/gŻel doustnyBezterminoweURPL RPL
PolandMoxisolv LABimeda Animal Health Ltd.100 mg/mlRoztwór do wstrzykiwańBezterminoweURPL RPL
PolandMoxodex LAChanelle Pharmaceuticals Manufacturing Ltd.100 mg/mlRoztwór do wstrzykiwańBezterminoweURPL RPL
PolandRidamecChanelle Pharmaceuticals Manufacturing Ltd.1 mg/mlRoztwór doustnyBezterminoweURPL RPL
United StatesmoxidectinChongqing Daxin Pharmaceutical Co. Ltd.PowderFDA NDC
United StatesMoxidectinZoetis Inc.PowderFDA NDC
United StatesMoxidectinJetpharmaPowderFDA NDC
United StatesMoxidectinMedicines Development for Global HealthTabletlistedFDA NDC
United StatesMoxidectinLivzon New North River Pharmaceutical Co., Ltd.PowderFDA NDC
United StatesMoxidectinLivzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.PowderFDA NDC
United StatesMoxidectinHisun Pharmaceutical (Hangzhou) Co., Ltd.PowderFDA NDC

See every manufacturer of Moxidectin worldwide →

Regulator price references for Moxidectin

Published list or reimbursement prices for Moxidectin presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

CountryProductStrengthPackPriceTypeSourceAs of
IcelandMoxodex0.1pctbrusi5,740.00 ISKmax wholesaleLyfjastofnun lyfjaverdskra2026-09-02
IcelandCydectin0.1pctbrusi6,933.00 ISKmax wholesaleLyfjastofnun lyfjaverdskra2026-09-02
IcelandMoxodex0.1pctbrusi14,350.00 ISKmax wholesaleLyfjastofnun lyfjaverdskra2026-09-02
IcelandCydectin0.1pctbrusi16,195.00 ISKmax wholesaleLyfjastofnun lyfjaverdskra2026-09-02
IcelandCydectin0.1pctbrusi37,500.00 ISKmax wholesaleLyfjastofnun lyfjaverdskra2026-09-02

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Cydectin (DIN 02228386) marketed in Canada?

No. Health Canada lists DIN 02228386 as Cancelled Post Market as of 31 Jan 2018.

Who holds the Canadian licence for this product?

Boehringer Ingelheim (Canada) Ltd Ltee is the company of record in the Health Canada Drug Product Database.

Is Moxidectin registered outside Canada?

Yes — Nexara Health has matched 22 registrations in 6 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02228386, status date 2018-01-31; national medicine registries: DH Drug Office, FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02228386, status date 2018-01-31; national medicine registries: DH Drug Office, FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra.

Health Canada Drug Product Database (DPD), DIN 02228386, status date 2018-01-31; national medicine registries: DH Drug Office, FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.